Eliminating AIDS has been an uphill battle. But Melbourne researchers just got one step closer
'We sort of took on this challenge to try and see if we could redesign the lipid nanoparticle. And that is eventually where I think the biggest breakthrough has been,' Paula Cevaal, lead author at the University of Melbourne, told ThePrint.
One of the reasons why HIV is a formidable opponent is because it hides inside our cells, making it difficult to eliminate them. The researchers combined different lipids—fats that can deliver treatment into the cell—into a fat bubble to deliver to the right cell where the virus is hidden.
Bengaluru: Eliminating AIDS is a Sisyphian challenge. Treatments mostly miss the Human Immunodeficiency Virus (HIV) that are hidden in the body. But in a breakthrough, a team of researchers from Melbourne have found a way to root out the virus hiding in our immune cells. They claim that they can reach 75 percent of infected cells.
The study, 'Efficient mRNA delivery to resting T cells to reverse HIV latency', was published in the Nature Communications journal.
Udayakumar Ranga, a professor at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), and who was not part of the study told ThePrint, 'Even if you have the best weapon in the world, there is nothing you can do to the virus because it is silent.'
The silent virus acts like a sleeper cell
Explaining why it's so difficult for the body to fight HIV, Ujjwal Rathore, Staff Research Scientist, University of California, said, 'Those (virus particles) just look essentially like any other cells which are uninfected (and) your immune system is unable to clear those infected cells.'
Rathore was not part of the study.
Usually to fight the virus, one needs to send mRNA—a messenger to tell the cells what proteins to make—to the cells to activate and kill the virus, a normal procedure in building vaccines. Then the T Cells, a type of white blood cells that fight infection, will be motivated to produce a protein to fight the virus.
Now the challenge is how to deliver that mRNA. The usual delivery of mRNA is not effective as it breaks down by the time it reaches the T cell. 'Whereas if you make and encapsulate this mRNA into lipids and lipid nanoparticles, then the stability of mRNA increases, and the delivery is possible into cells,' Rathore added.
Inside the cell, the delivery partner knocks on the door of the T cells. Then the unboxing begins—the endosomal escape mechanism. '(This) will break down the mRNA assembly or the cargo when in contact with the T-cell. Then the mRNA will be released, and that mRNA will start expressing the protein, the targeted protein,' explained Mrinmoy De, Associate Professor, Department of Organic Chemistry, Indian Institute of Science (IISc).
With the help of the newly designed LNP (the delivery partner), the researchers used HIV's own 'master switch' protein—called Tat—to force hidden virus out of dormant immune cells.
The study is carried out by taking cells from humans, in a petri dish inside the laboratory and not on humans. 'We haven't done in this study anything in animal models or anything in people. We're not there yet,' said Cevaal.
Cevaal's study showed that one can force the hidden virus out of hiding in infected cells. However, simply revealing the virus is not enough—a second step to boost the immune attacks or adding antiviral drugs will be critical to fully clear the virus.
Imagine the virus is a thief hiding in one of many rooms in a huge palace. To catch the thief, the cops must search every single room. HIV, just like a thief, can hide in any of the CD4, special type of immune cells. So when the war room is highjacked by the HIV sleeper cells, the immunity system collapses.
This is the issue with HIV, which can enter any of the many CD4 cells in the body and hide there. To pop out the stealthy virus, the drug must enter every individual cell, like an encounter specialist.
'Only one in 10,000 to 100,000 CD4 cells may harbour a hidden virus. The therapy of making a drug enter every cell has its undesirable side effects,' said Ranga. According to Ranga the researchers did something smart. They delivered a Tat protein in the form of mRNA and was made to pop into the cells with the help of specially designed LPN.
'However, Tat protein itself is highly toxic and can cause cell death,' Ranga added. So even though they do not activate the cells, the danger remains.
'Of course this is an essential question that we are studying at the moment and that we will continue to study closely. We will perform experiments to test whether they (healthy cells) are affected by the presence of this Tat protein and up to what extent,' Cevaal added.
The potential of such studies depends on how they translate into a technology to reach patients.
'We are very much aware that the pursuit to try and resolve the HIV AIDS pandemic is very much not a done deal, that's really triggering us to continue working in this area to design a new therapeutic,' Cevaal added.
(Edited by Sanya Mathur)
Also Read: Eradicating malaria or mosquitoes? Gene editing raises ethical questions
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
12 hours ago
- Time of India
Trump aid cuts deal a blow to HIV prevention in Africa
Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump 's administration cut access for at-risk groups like gay men and injecting drug users to medication that prevents infection. Cherem admits he should have been more careful about practicing safe sex but had become accustomed to using the U.S.-supplied pharmaceutical. The drug - known as Pre-Exposure Prophylaxis, or PrEP - is typically taken daily as a tablet and can reduce the risk of contracting HIV through sex by 99%. "I blame myself... Taking care of myself is my first duty as a person," Cherem said at his gym in Awka, the capital of Nigeria's southeastern state of Anambra. "I equally blame the Trump administration because, you know, these things were available, and then, without prior notice, these things were cut off." Trump ordered a 90-day pause on foreign aid after taking office in January and halted grants by the U.S. Agency for International Development (USAID). The agency was responsible for implementing the bulk of the assistance under the President's Emergency Plan for AIDS Relief ( PEPFAR ), the world's leading HIV/AIDS initiative. Sub-Saharan Africa remains the epicenter of the AIDS pandemic. Trump's cuts have restricted the availability of drugs that millions of Africans have taken to prevent infection - particularly vulnerable communities such as gay men and sex workers - as aid groups and public health systems in Africa strove to roll back the disease. The number of initiations, or people who have taken at least one dose of the drug, rose in Africa from fewer than 700 in 2016 to more than 6 million by late 2024, according to PrEPWatch, a global tracker. More than 90% of new initiations last year were financed by PEPFAR, using cheap generic versions of the drug. Sub-Saharan Africa had 390,000 AIDS-related deaths in 2023, or 62% of the global total, according to UNAIDS, the United Nations AIDS agency. However, progress has been made: that death toll was down by 56% from 2010, according to the World Health Organization. Now, some of those who've lost access to the preventative medication because of U.S. cutbacks are already testing positive, according to 10 patients, health officials and activists. Restrictions on PrEP have coincided with dwindling supplies of more widely used HIV prevention tools like condoms and lubricants "because of the US funding cuts", according to a UNAIDS fact sheet from May. The combination is creating what nine activists and three medical experts described as a major threat to prevention across the continent. "I just see this as incredibly short-sighted because we were on a winning path," said Linda-Gail Bekker, an HIV expert at the University of Cape Town. She said that many African governments did not have the resources to spend on PrEP drugs on top of treatment for HIV infections, risking a worsening of the pandemic. "It's as predictable as if you take your eye off a smouldering bushfire and the wind is blowing: a bushfire will come back." Trump has said that the United States pays disproportionately for foreign aid and he wants other countries to shoulder more of the burden, as he seeks to reduce U.S. government spending across the board. The U.S. disbursed $65 billion in foreign assistance last year, nearly half of it via USAID, according to government data. "It's a question of who has primary responsibility for the health needs of citizens of other countries, and it's their own governments," said Max Primorac , a former senior USAID official who is now senior research fellow at The Heritage Foundation's Margaret Thatcher Center for Freedom. "We all know, and this is a bipartisan issue, that aid dependency doesn't help these people - that the best solution is for these countries to be able to take over the responsibility of these programs." A RISE IN CASES UNAIDS says the permanent discontinuation of PEPFAR-supported prevention and treatment programs could lead to an additional 2,300 new HIV cases globally per day. There were 3,500 new cases per day in 2023. Reuters spoke to 23 health workers, PrEP users and activists, nearly all of whom said that the increase in HIV infections since the funding cuts was impossible to quantify because many organisations working with vulnerable populations have been defunded. A State Department waiver issued on February 1 allowed some PEPFAR activities to restart, but only covered HIV prevention for mother-to-child transmission. That means PEPFAR-financed PrEP is no longer available for gay and bisexual men, sex workers and injecting drug users who are especially exposed to the virus. Many African governments had specifically targeted these groups in their PrEP programs. A spokesperson for the State Department, which oversees USAID and the PEPFAR program, told Reuters it "continues to support lifesaving HIV testing, care and treatment, and prevention of mother to child transmission services approved by the Secretary of State." "All other PEPFAR-funded services are being reviewed for assessment of programmatic efficiencies and consistency with United States foreign policy," the spokesperson said. The spokesperson did not directly respond to a question about why the waiver had excluded vulnerable groups from PrEP distribution. In East and Southern Africa, the sub-region that accounts for more than half of all people living with HIV, the U.S. had been funding nearly 45% of HIV prevention programming, UNAIDS said in March. Some countries like Malawi, Zimbabwe and Mozambique were almost entirely dependent on PEPFAR for their HIV prevention programs, the agency said. In some wealthier nations, like South Africa and Kenya, PEPFAR represented less than 25% of spending on HIV prevention. Russell Vought , the director of the U.S. Office of Management and Budget, told a Congressional committee on June 4 that, due to high U.S. debt levels, Africa needed to shoulder more of the burden in fighting AIDS. Asked specifically about restrictions on HIV prevention programs, Vought said: "We believe that many of these nonprofits are not geared toward the viewpoints of the administration." His office did not respond to a request for further details. 'I PRAY TRUMP CHANGES HIS POLICY' Reuters spoke to four PrEP users in Nigeria, all gay or bisexual men, who have tested positive for HIV since January when they stopped being able to obtain more pills, after practicing unsafe sex. Hearty Empowerment and Rights (HER) Initiative, a community-based organisation in southeastern Nigeria, worked with other groups that provide HIV/AIDS services to confirm the men's diagnosis and help secure treatment for them, said executive director Festus Alex Chinaza. In Asaba, the capital of Nigeria's Delta state, Echezona, a 30-year-old gay man who took PrEP pills daily for more than three years, is struggling to come to terms with his HIV-positive test result, which he received in early May. He regrets that he had unprotected sex. "I just pray and wish that Trump actually changes his policy and everything comes back to normal so that the spread and transmission of the virus would be reduced," said Echezona, who asked to be identified only by his first name for fear of stigma. Like the other three men, he described being told by staff at community-based clinics that PrEP was only available to pregnant and lactating women, in line with the Trump administration guidelines. Nigeria has an adult HIV prevalence rate of 1.3% and an estimated 2 million people living with HIV, the fourth-highest total globally, according to UNAIDS. But for so-called key populations, the rates are much higher: 25% for men who have sex with men, according to a survey completed in 2021. The Nigerian health ministry did not respond to a request for comment on the effects of the Trump administration's cuts to HIV prevention services. South Africa - which has an estimated 7.7 million people living with HIV, according to UNAIDS, the highest number in the world - pays for its own PrEP pills. But some clinics where so-called key populations obtained them relied on PEPFAR grants and have been forced to close in recent months. PrEP is also available for free at public health centers, but gay men and sex workers often avoid such facilities, fearing discrimination and harassment, nine activists said. Francois Venter, executive director of the Ezintsha medical research center at the University of the Witwatersrand in Johannesburg, said PrEP distribution from public sector clinics in the city had shown almost no increase since the Trump cuts. Foster Mohale, spokesperson for South Africa's health ministry, said the ministry was "not aware" of reports that key populations were avoiding health facilities due to stigma. "We have sensitized health officials across the country to create (a) conducive environment for all healthcare seekers/clients to access the service without feeling judged or discriminated against," he said. (Reporting and writing by Robbie Corey-BouletAdditional reporting by Seun Sanni in Awka, Nigeria, Nellie Peyton in Johannesburg, Amindeh Blaise Atabong in Yaounde, Ange Adihe Kasongo in Kinshasa, Maxwell Akalaare Adombila in Accra and Jennifer Rigby in London. Editing by Daniel Flynn)
The Print
13 hours ago
- The Print
Yoga marks beginning of inner peace becoming global policy: PM Modi
After 11 years, Yoga has now become part of the lives of crores of people around the world, he further said adding. 'whether the Sydney Opera House or Everest mountain or the span of the ocean, the message is that Yoga is for everyone.' The PM said some tensions or others were happening around the world. Addressing the 11th International Yoga day participants here, Modi said when India proposed June 21 to be celebrated as International Yoga day in the United Nations, in a short time 175 countries accepted it. Visakhapatnam (Andhra Pradesh), Jun 21 (PTI) Yoga leads people on a journey towards oneness with the world while the International Yoga Day marks the beginning of the ancient practice for humanity where inner peace becomes global policy, Prime Minister Narendra Modi said on Saturday. 'My request to the world– let this Yoga day mark the beginning of Yoga for humanity 2.0 where inner peace becomes global policy,' he said. He further said Yoga leads us on a journey towards oneness with world. Further, Yoga is for everyone, beyond boundaries, backgrounds, age or ability, the PM said. Yoga is a great personal discipline, also a system that takes people from 'Me to We' and is the pause button that humanity needs to breath, balance to become whole again, he added. The PM later joined the volunteers to perform Yoga. Andhra Pradesh Chief Minister N Chandrababu Naidu also spoke at the event. Naidu said Modi made Yoga popular not only in India but across the world, turning it into a global wellness movement. Naidu highlighted that Yoga Day is being celebrated in more than 175 countries, across 12 lakh locations with the participation of over 10 crore people. 'I am thanking our visionary Prime Minister Narendra Modi for making Yoga popular not only in India (but also) across the world. He started International Yoga Day through the United Nations and made Yoga a global wellness movement,' said Naidu. PTI STH GDK SA This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Time of India
17 hours ago
- Time of India
A shot of hope
New HIV medicine is powerful – but can everyone afford it? A new medicine called lenacapavir has just been approved in the US to help stop people from getting HIV, the virus that causes AIDS. That's big news! Even though fewer people are getting HIV today than in the 1990s, around 13 lakh (1.3 million) people still get infected every year around the world. Lenacapavir is special because you only need two shots a year – not a pill every day like older medicines. That's great for people who forget daily pills or feel embarrassed taking them. And it's almost 100% effective at stopping HIV in adults and teens. But there's a big problem: the cost. In the US, it sells for over ₹23 lakh a year! Even rich countries find that hard to afford. The company that makes it, Gilead, is working with more than 100 poorer countries to help them make cheaper versions. Still, many African countries where HIV is most common may struggle to get it to the people who need it most. Scientists have been trying to create a proper HIV vaccine for decades, but HIV keeps mutating – changing too fast for one shot to work. New mRNA vaccines (like the ones used for Covid) are being tested, but funding cuts in the US have slowed down this research. That's why lenacapavir gives us hope. But hope only works if everyone, everywhere, can afford it. Facebook Twitter Linkedin Email Disclaimer Views expressed above are the author's own.
